What investigations are needed for a stable newborn with an ear tag on the right ear?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hearing Assessment is Required for Newborns with Ear Tags

All newborns with isolated ear tags (preauricular tags) should undergo hearing assessment, as they are at significantly increased risk for hearing impairment compared to the general population.

Why Hearing Assessment is Necessary

Ear tags are classified as a craniofacial anomaly and represent a specific risk indicator for hearing loss according to the American Academy of Pediatrics Joint Committee on Infant Hearing 1. The evidence demonstrates:

  • 13-17% of infants with isolated ear tags have hearing impairment, which is significantly higher than the general population 2, 3
  • Both sensorineural and conductive hearing loss can occur with isolated ear tags 2, 3
  • 78% of children with ear tags and hearing impairment have a hereditary tendency for hearing loss 2
  • The presence of ear tags, ear pits, or temporal bone anomalies specifically triggers the need for comprehensive hearing evaluation 1

Recommended Investigation Protocol

Immediate Actions:

Hearing Assessment:

  • If the newborn passed the initial hospital hearing screening, repeat hearing assessment is still required due to the ear tag being an independent risk factor 1
  • If the newborn failed or did not receive hospital screening, refer for comprehensive audiological evaluation by 3 months of age 4, 5
  • The evaluation should include diagnostic ABR testing (not just OAE screening), as this can detect both cochlear and neural hearing loss 5, 6

Physical Examination:

  • Carefully examine for other craniofacial anomalies including ear canal atresia/stenosis, facial asymmetry, branchial cleft cysts, cleft palate, and dental anomalies 1
  • Document any dysmorphic features that might suggest a syndrome (e.g., Goldenhar, branchio-oto-renal syndrome) 1
  • Check for white forelock, heterochromia irides, or abnormal pigmentation (Waardenburg syndrome) 1

Family History:

  • Obtain a three-generation pedigree focusing on hearing loss, consanguinity, and craniofacial anomalies 1
  • Ask specifically about childhood hearing loss in relatives (29% of children with ear tags have positive family history) 2

Additional Investigations to Consider:

Renal Ultrasound:

  • Newborns with isolated ear tags have increased risk of congenital urinary tract malformations 7
  • This is particularly important as ear tags can be associated with branchio-oto-renal syndrome 1

Cardiac Evaluation:

  • Consider cardiac ultrasound as ear tags are associated with increased risk of congenital heart malformations 7
  • Obtain ECG if there are any cardiac symptoms or family history of sudden death (to screen for prolonged QT syndromes like Jervell and Lange-Nielsen) 1

Ophthalmology Referral:

  • All infants with confirmed hearing loss should have ophthalmology evaluation to screen for associated visual anomalies 1

Genetics Consultation:

  • Refer to clinical geneticist if multiple anomalies are present or if hearing loss is confirmed 1
  • Genetic testing (including GJB2/connexin 26) may be appropriate if hearing loss is documented 1

Ongoing Surveillance

Long-term Monitoring:

  • Even if initial hearing assessment is normal, children with ear tags require ongoing developmentally appropriate hearing screening 1
  • At minimum, perform one diagnostic audiology assessment by 24-30 months of age 4, 5
  • This is critical because some forms of hereditary hearing loss are progressive or late-onset 1

Common Pitfalls to Avoid

  • Do not assume normal newborn hearing screening is sufficient - ear tags are an independent risk factor requiring additional assessment 1
  • Do not rely solely on OAE screening - diagnostic ABR is needed to detect neural hearing loss 5, 6
  • Do not dismiss isolated ear tags - even without other anomalies, the hearing impairment risk is 13-17% 2, 3
  • Do not forget to assess for associated anomalies - 19% have other congenital malformations 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hearing impairment in connection with preauricular tags.

Acta paediatrica Scandinavica, 1987

Research

Preauricular tags and pits in the newborn: the role of hearing tests.

Acta paediatrica (Oslo, Norway : 1992), 1997

Guideline

Newborn Screening Follow-up Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Newborn Hearing Screening and Follow-up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Newborn Hearing Screening Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management and treatment approach for a pediatric patient with agenesis of the external auditory canal (EAC) and potential associated craniofacial anomalies?
What is the difference between the external and internal ear canal?
Are babies with ear skin tags at risk for urinary tract anomalies?
What is the risk of renal anomalies in babies born with preauricular (ear) tags?
Should a 4-month-old infant with an ear tag and no audible murmur undergo an echocardiogram (echo) and ultrasound of the kidneys, ureters, and bladder (USG KUB) as part of their diagnostic workup?
What is the appropriate management for an adult patient with underlying heart disease or malignancy presenting with Infective Endocarditis, cough, and Marantic Embolus?
What are the indications for intrastromal antifungal (IAF) injections in patients with fungal keratitis?
How does the Patient Health Questionnaire-9 (PHQ-9) contribute to preventative care in patients with depressive symptoms?
Can Omega 3 (fatty acid) supplements be used to manage hypertension in patients with elevated triglycerides or increased risk for cardiovascular events?
What investigations are needed for a 61-year-old male with a 12-year history of diabetes mellitus and hypertension, currently on Tab Oxramet S XR (Metformin, Gliclazide, Pioglitazone) 10/100/1000mg, Tab Reclimet (Vildagliptin, Metformin) 60/500mg, Tab Rosuvas (Rosuvastatin) 10mg, and Tab Telmikind H (Telmisartan, Hydrochlorothiazide) 40/12.5mg, to maintain a healthy life?
What is the difference in treatment approach between primary and secondary hyperparathyroidism (hyperparathyroidism due to chronic kidney disease or vitamin D deficiency)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.